Summary
With difficulties in research for pediatric cancer treatments the FDA RACE for Children Act brings hope for curing childhood cancer, and saving the lives of our most vulnerable members of society.
By Jacqui Whiteway and Missy Hansen
View Publication
Surviving isn't Thriving: FDA RACE for Children Act brings hope for curing childhood cancer
View International Clinical Trials August 2020 article
You may also be interested in:
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
View Resource
Blog
Fighting Mesothelioma
Read Story
Blog
Search for a Cure: Fighting Children's Cancer
Read Story
View all related content and resources for Oncology
Explore Insights